Latest News & Features
Americas
On January 28, Teva announced that the FDA had approved its supplemental new drug application for a new formulation of its biggest selling drug Copaxone. 29 January 2014
Big Pharma
The UK High Court has decided to award Slovenian generic pharmaceutical company KRKA damages after a preliminary injunction enforced against the company by AstraZeneca was discharged. 28 January 2014
Americas
Law firm Blank Rome LLP has expanded its IP litigation group with the appointment of Christopher Hu. 28 January 2014
Americas
Johnson & Johnson has been named the most effective pharmaceutical company on social media, in a new report. 27 January 2014
Asia
A government-appointed panel in India is preparing to evaluate more patented drugs for local generic pharmaceutical companies to mimic, according to reports. 24 January 2014
Asia
Teva has agreed to acquire pharmaceutical company NuPathe for $144 million. 23 January 2014
Big Pharma
Pharmaceutical company Novo Nordisk has left a group of pharmaceutical companies that are unhappy with proposed drug laws in South Africa. 23 January 2014
Americas
The US Supreme Court has ruled that when licensees seek a declaratory judgement of non-infringement, the patentee bears the burden of proof to show infringement. 22 January 2014
Americas
The US Court of Appeals for the Federal Circuit has upheld a ruling which found that the US Patent and Trademark Office had been incorrectly calculating Patent Term Adjustment lengths. 21 January 2014
Americas
On January 17, Actavis confirmed that the US District Court for the District of New Jersey found its US patent 7,704,984, which covers Lo Loestrin Fe birth control pills, to be valid and infringed by Lupin and Amneal. 21 January 2014